Drugs / rMenB+OMV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02141516 Comparator | May 2014 → Mar 2015 | meningococcal infection | Novartis | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rMenB+OMV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02141516 ↗ |